EFFECTIVENESS OF RADIATION THERAPY IN THE TREATMENT OF CARCINOMA OF THE ESOPHAGUS*

Size: px
Start display at page:

Download "EFFECTIVENESS OF RADIATION THERAPY IN THE TREATMENT OF CARCINOMA OF THE ESOPHAGUS*"

Transcription

1 APRIL, 1970 EFFECTIVENESS OF RADIATION THERAPY IN THE TREATMENT OF CARCINOMA OF THE ESOPHAGUS* A RETROSPECTIVE STUDY Bv A. B. l RAZIER, M.I)., S. H. LEVITT, M.D., and L. S. DEGIORGI, M.D. RICHMOND, CARCINOMA of the esophagus is one of the most discouraging diseases that the radiotherapist encounters. The 5 year survival rate had! been und!er 5 per cent, according to most ofthe early series. 37 \\Tith tile advent of megavoltage therapy and more radical therap\r regimens, there has been a slight but definite reported increase in the 5 year survival rate of between 5 per cent and 10 per cent Somewhat more encouraging is the reported increase in the average survival rate, which approaches I year in some series.4 8 This may reflect greater selectivity as we!l as improved! methods of treatment. Surgical results have been variable but generally are no better than those of radiiation therapy, and are associated! with a considerable operative mortality of from between 10 per cent and! 40 per cent.1 8 Generally, surgery is used for the more favorable lesions and for patients who are in good physical condition. Comparison of the results of surgery and! radiation tilerapy is therefore not feasible. In evaluating the results of treatment in this dhsease, it is important to consider not only the curative role, but also the palliative role. therapy has long been recognized! as a prime palliative agent in carcinoma of the esophagus. However, despite this prolonged! use, the contraindications and ind!ications for the utilization of rad!iation therapy are not well d!efined. It is the purpose of this study to evaluate the result of both curative and palliative radiation therapy and! to ascertain if possible the indications and contraindications for the use of this form of treatment. VIRGINIA MA I ERIAL AND METHOD The clinical course of 90 patients treated at the Medical College of Virginia from J anuary 1961 to December 1966 was reviewed. Included were only those patients treated by rad!iation therapy alone and/or surgery plus radiation therapy. The age of the patients ranged! from 3 years to 84 years of age. There were 68 males and 22 females. Nineteen (21 per cent) of the lesions were in the upper third of the esophagus, 47 (52 per cent) were in the middle third and 24 (26 per cent) were in the lower third. Twelve of the 7 patients having a mid!dle third lesion had! extension into the upper or lower third making it difficult to (Jetermine the point of origin of the lesion. This accounts for the increased! incidence of middle third lesions in our series when compared! with the other series. 7 therapy was given using either cobalt 6o or a 2 mev. Maxitron unit. The majority of patients were treated through opposing anterior and posterior ports. Some were treated with i anterior and! 2 posterior ports. One patient was treated with rotational therapy. In I I patients the lesions were resected; 5 patients received preoperative radiation therapy and! 6 received! postoperative radiation therapy. The over-all survival statistics included all 90 patients, but the i I who had surgery are excluded from the other categories, exdept where specified. All survivals were counted from the start of irrad!iation: 13 patients (14 per cent) survived i year; 3 patients per cent) survived 2 years; and i patient of the 90 is now surviving 5 * Presented at the Sixty-ninth Annual Meeting of the American Roentgen Ray Society, New Orleans, Louisiana, October 1-4, From the Division of, Department of Radiology, Medical College of Virginia, Richmond, Virginia. 830

2 VOL. io8, No. Carcinoma of the Esophagus 831 years after esophagectomy and postoperative irradiation (Tables i and ii). Correlation of the length of the lesion with survival is shown in Table in for both the radiation therapy and radiation therapy plus surgery groups. Measurements were taken from the roentgenographic reports, when given, and for the rest the roentgenograms were reviewed and the lesion measured. Because ofsubmucosal extension in many cases, the true extent of the lesion could! not be determined. As expected, the larger the lesion, the worse the survival. Follow-up roentgenograms were obtained in about half the cases. Interestingly, some patients who showed a marked radiographic improvement did not obtain complete symptomatic relief. The effects of the most common complication of the disease process and/or treatment on survival were evaluated. These included : ( I ) tracheoesophageal fistulae; (2) obstruction of esophagus by tumor; or (3) stricture after radiation therapy. In our series, 36 of the 90 patients (40 per cent) developed or previously had one or more complications. Ten patients developed tracheoesophageal fistulae: 3 before radiation therapy was started; 2 during radiation therapy, and 5 after completed treatment. As shown in Table Iv, when fistulae developed before starting radiation therapy, the average survival was only I.7 months and the patients could not finish the planned course of therapy. When fistulae developed during radiation therapy the patients did little better. One patient had a fistula develop during the course of rad!iation therapy, had it re- TOTAL I ATIENTS IN STUDY I Yr. 2 Yr. 5 Yr. No. of T No. Per Cent I T No. Per Cent No. Per Cent I 3.5 SURVIVAL CORRELATED WITH TYPE OF TREATMENT No.of. PatIents II Average. Mediaṇ SurVlval Total patients in Study with 79 6.i only withsurgery ii and paired and was able to finish the planned! course of therapy, but expired 2 weeks later. One patient developed! a tracheoesophageal fistula i6 months after preoperative radiation therapy and partial esophagectomy. He survived for 2 more months after developing the fistula. Sixteen patients became obstructed and! had a gastrostomy performed; 7 of these before radiation therapy was started. This later group had an extremely low average survival of2.6 months and! frequently could! not finish the full course of therapy. Even more significant was the fact that they did not obtain any relief of their symptoms of dysphagia and drooling. Likewise, those patients who became obstructed during SURVIVAL CORRELATED WITH LENGTH OF THE LESION III No.of. Averagẹ. A. 0-5 cm. in Length Surgery and 6 i6.o 6 B. 6 cm. and Above I Surgery and

3 832 A. B. Frazier, S. H. Levitt and L. S. DeGiorgi APRIL, 1970 IV COMPLICATIONS RELATED TO SURVIVAL (All ) Tracheoesophageal fistulae io A. Before Started! I B. During C. After. 7. S 7.0 Obstruction requiring gastrostomy A. Before Started! B. After 9 1 I therapy and required a gastrostomy had! a very low average survival of 4.2 months. Stricture requiring dilatation developed in 10 patients following rad!iation therapy. The average survival for this group was 5.75 months. related to tumor dose is shown in Table v. Of the patients receiving less than 3,000 rads, 5 were preoperative patients who received 2,000 rads, 2 had recurrent lesions, and io were patients who did not finish their course of therapy, due to debility or death. The 3 patients receiving more than 6,ooo rad!s tumor!ose had an average survival of i6.6 months. The relation between the type of therapy and survival is noted in Table vi. Although there is an apparent difference in average survival, the median survival in all groups is similar. Pain, dysphagia, weight loss, and! weak- SURVIVAL CORRELATED WITH RADIATION DOSE Dose No. of Total 79 V Average Under3,ooorads ,Iooto4,000rads ,Iooto5,000rads ,Iooto6,000rads o 6,iooradsandabove 3 i6.6 8.o No. of Per Cent of Average Total ness were tile symptoms evaluated!. Almost 50 per cent ofour patients failed to achieve significant relief of their symptoms and! all of these had a very low over-all average survival of about 3.2 months (Table vii). Likewise, those patients requiring more than weeks to adllieve relief of symptoms had a lower average survival than those patients receiving relief in a shorter period. Other factors which were found! to be present in those patients not palliated were: ( i) demonstrable metastases at the start of radiation therapy; (2) the presence of tracheoesophageal fistulae ; (,) gastrostom y prior to or development of a stricture during radiation therapy; and! (.) poor general condition prior to starting rad!iation therapy. Preoperative Postoperative Only DISCUSSION The effectiveness of any therapeutic VI SURVIVAL AFTER RADIATION THERAI Y COMI ARED WITH SURGERY No. of Average

4 VOL. io8, No. Carcinoma of the Esophagus 833 agent is measured by the ability of this agent to cure the disease, arrest the disease process and/or offer symptomatic relief. This study was initiated to evaluate the effectiveness of radiation therapy as an agent in the treatment of carcinoma of the esophagus and to ascertain the indications, contraindications and complications of this agent. The over-all survival of our group of patients is fairly low when compared to more recent series with more radical therapy.3 8 This may partially be explained! on the basis that little or no selection of patients for treatment was attempted!. Almost all patients, regardless of extent of disease or physical condition, were treated!. The average survival in months for all patients was 5.77 months, but when onl those who finished their planned! course of radiation therapy were considered!, it was increased! to 7.3 months. Most recent series have an average survival ofabout 12 months. Factors that affected survival in this series were: (i) length of the lesion when diagnosed; (2) presence or absence of metastases; (3) complications before or (luring radiation therapy; (4) response to rad!iation therapy as gauged by symptomatic relief; and () radiation dosage. Although there appeared to be improved survival in the surgically treated group, there was no difference in median survival. This apparent difference in survival could be explained by the fact that the patients receiving the combination treatment were generally patients with less advanced d!isease than those receiving radliation therapy alone (Table iii). From the small group, one cannot draw any conclusions concerning the effectiveness of combination of stirgery and radiation therapy when compared! to radiation therapy alone. However, one cannot help but wonder if an actual advantage to the patient is obtained by the use of surgery when the operative mortality and postoperative morbidity and questionable improvement in survival are considered!. Symptomatic relief was adversely affected by: (i) complications; (2) metas- Relief in I -4 Weeks Relief in 4 or More Weeks No Significant Relief VII SURVIVAL AND RELIEF OF SYMPTOMS ( Only) No. of Average 30 (38%) II 7 10(12.7%) (.%)._). - tases; and () the general condition of the patient. The length of the lesion did not correlate too well with symptom relief. The general condition of the patient, individual tumor responsiveness to radiation therapy, and! biologic differences between patients may account for this apparent inconsisten cv. A significant factor in this series was the poor survival and poor symptomatic response of those patients with major cornplications before radiation therapy was started, or who developed them during radiation therapy. with obstruction requiring gastrostomy prior to irradiation had an average survival of 2.6 months. Besid!es the poor survival, these patients did not obtain symptomatic relief of their distressing cornplaints of d sphagia and excessive drooling. requiring gastrostomv during treatment had a survival of4.2 months and! also no relief of symptoms of d!rooling and! pain after the gastrostomy was performed!. For these reasons it is felt that radiation therapy is not indicated after a patient has had a gastrostomy and should be stopped if a gastrostorny is required! during the course of treatment. developing tracheoesophageal fistulae before or during therapy also had! a low average survival. Those patients who had fistulae before treatment had an average survival of 1.7 months, and no relief of symptoms. developing fistulae during treatment also had a short sur-

5 834 A. B. Frazier, S. H. Levitt and L. S. DeGiorgi APRIL, 1970 vival and no relief of symptoms. For these reasons and because of the dangers of producing a mediastinitis, it is felt that initiaflon or continuation of radiation therapy is not indicated in these patients. Our findings and recommendations in these patients appear to be in contrast to those of Marcial et al.,5 who felt that development of fistulae was not a contraindication to radiation therapy and indeed fails to treat only when the patient s general physical condition has deteriorated to such a state that he cannot be transported to the Radiotherapy Departrnent. After careful analysis of our series, we feel that selectivity should be shown in treating carcinoma of the esophagus. Gastrostomy and tracheoesophageal fistulae before starting treatment are contraindications to radiation therapy. Also, if gastrostomy is required or tracheoesophageal fistulae (ievelop during the course of radiation therapy, then treatment should be stopped, as little or no symptom relief is obtained and there is such a low survival. with obvious metastases should have only a supportive therapy. SUMMARY A review of 90 patients with carcinoma of the esophagus, treated! at the Medical College of Virginia from January, 1961 through December, 1966, is presented. Factors affecting survival and symptomatic relief are discussed!. The following points are stressed: (I) obstruction requiring gastrostomy before or during radiation therapy is a contraindication to starting or continuing rad!iation therapy (lue to the poor survival and lack of symptomatic relie1; (2) the development of a tracheoesophageal fistula before or during the course of radiation therapy is a contraindication to further irradiation; () a tumor dose of at least 5,000 to 6,ooo rads or above should be our goal whenever there are no contraindications; (4) palliative radiation therapy should be attempted to prevent esophageal obstruction when more radical therapy is not indicated; (5) in this series the addition of radiation therapy to surgery whether pre- or postoperatively did not significantly alter the cure or survival statistics. S. H. Levitt, M.D. Division of and Oncology Medical College of Virginia Richmond, Virginia REFERENCES I. ACKERMAN, L. V. and DEL REGATO, J. A. Cancer Diagnosis, Treatment and Prognosis. C. V. Mosby Company, St. Louis, CHRI5TIAN5EN, K. H., PINCH, L. W., and STAIN- BACHN, \V. Carcinoma of esophagus. Am. 7. Surg., 1966,3, H0L5TI, L. Split-course megavoltage radiotherapy: one-year follow-up. Brit. 7. Radiol., 1966, 39, LEDERMAN, M. Carcinoma of oesophagus with special reference to upper third. Brit. 7. Radiol., 1966,39, MARCIAL, V. A., BOSCH, A., CORREA, J. N., and TOME, J. II. Role of radiation therapy in esophageal cancer. Radiology, 1966, 87, MERENDINO, K. A., and MARK, V. H. Analysis of one hundred cases of squamous cell carcinoma of esophagus. Surg., Gynec. & Obst., 1952, 94, II0-II4. 7. Moss, W. T. Definitive radiation therapy for carcinoma of breast. Radiology, I965, 83, I. 8. PEARSON, J. G. Radiotherapy of carcinoma of oesophagus and post cricoid region in South East Scotland. C/in. Radiol., 1966, 7,

6 This article has been cited by: 1. J. Sule-Suso, A.M. Brunt, R. Lindup, J.E. Scoble Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Clinical Oncology 3:4, [CrossRef] 2. Richard Belgrad, Galen L. Wampler A pilot study with ethyl bis (2,2-dimethyl-1-aziridinyl) phosphinate (AB-163) and radiation therapy. International Journal of Oncology*Biology*Physics 8:7, [CrossRef] 3. V.A. Piccone, N. Ahmed, S. Grosberg, H.H. LeVeen Esophagogastrectomy for Carcinoma of the Middle Third of the Esophagus. The Annals of Thoracic Surgery 28:4, [CrossRef] 4. V.A. Piccone, H.H. LeVeen, N. Ahmed, S. Grosberg Reappraisal of esophagogastrectomy for esophageal malignancy. The American Journal of Surgery 137:1, [CrossRef]

LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE

LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE LIFE EXPECTANCY AND INCIDENCE OF MALIGNANT DISEASE IRA T. NATHANSON,' M.S., M.D., AND CLAUDE E. WELCH,2 M.A., M.D. (From the Collis P. Huntington Memorial Hospital, Harvard University, Boston, Mass., and

More information

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds ESOPHAGEAL CANCER Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds ESOPHAGEAL CANCER I. EPIDEMIOLOGY INCIDENCE, DIAGNOSIS & STAGING II. TREATMENT OPTIONS Current role of induction therapies

More information

The Role of Radiation Therapy

The Role of Radiation Therapy The Role of Radiation Therapy and Surgery in the Treatment of Bronchogenic Carcinoma R Adams Cowley, M.D., Morris J. Wizenberg, M.D., and Eugene J. Linberg, M.D. A study of the combined use of preoperative

More information

Transhiatal Esophagectomy: Lower Mortality, Diminished Morbidity, Equal Effectiveness

Transhiatal Esophagectomy: Lower Mortality, Diminished Morbidity, Equal Effectiveness Transhiatal Esophagectomy: Lower Mortality, Diminished Morbidity, Equal Effectiveness Sunil Malhotra, M.D. Department of Surgery University of Colorado Resident Debate April 30, 2007 Esophageal Cancer

More information

Esophageal Ulceration Induced by Intracavitary Irradiation for Esophageal Carcinoma

Esophageal Ulceration Induced by Intracavitary Irradiation for Esophageal Carcinoma 269 Yoshio Hishikawa1 Shinichi Tanaka Takashi Miura Received January 23, 1984; accepted after revision April 5. 1984. All authors: Department of Radiology, Hyogo College of Medicine, 1-1, Mukogawa-cho

More information

Carcinoma of the Lung in Women

Carcinoma of the Lung in Women Carcinoma of the Lung in Marvin M. Kirsh, M.D., Jeanne Tashian, M.A., and Herbert Sloan, M.D. ABSTRACT The 5-year survival of 293 men and of 78 women undergoing pulmonary resection and mediastinal lymph

More information

Kawahara, Katsunobu; Tomita, Masao. Citation Acta Medica Nagasakiensia. 1992, 37

Kawahara, Katsunobu; Tomita, Masao. Citation Acta Medica Nagasakiensia. 1992, 37 NAOSITE: Nagasaki University's Ac Title Author(s) TRANSHIATAL ESOPHAGECTOMY FOR CARCI THORACIC ESOPHAGUS Ayabe, Hiroyoshi; Tsuji, Hiroharu; Kawahara, Katsunobu; Tomita, Masao Citation Acta Medica Nagasakiensia.

More information

Pulsion Intubation Versus Traction Intubation for Obstructing Carcinomas of the Esophagus

Pulsion Intubation Versus Traction Intubation for Obstructing Carcinomas of the Esophagus Pulsion Intubation Versus Traction Intubation for Obstructing Carcinomas of the Esophagus Helmut W. Unruh, M.D., F.R.C.S.(C), and K. Michael Pagliero, M.B.B.S., F.R.C.S. ABSTRACT Eighty-eight patients

More information

THE CLASSIFICATION OF BLADDER TUMOURS

THE CLASSIFICATION OF BLADDER TUMOURS 41 THE CLASSIFICATION OF BLADDER TUMOURS T. J. DEELEY AND V. J. DESMET* From the Radiotherapy Department, Hammersmith Hospital, Du Cane Road, London, IF7.12, and the Department of Pathology, Louvain University,

More information

The use of metallic expandable tracheal stents in the management of inoperable malignant tracheal obstruction

The use of metallic expandable tracheal stents in the management of inoperable malignant tracheal obstruction The use of metallic expandable tracheal stents in the management of inoperable malignant tracheal obstruction Alaa Gaafar-MD, Ahmed Youssef-MD, Mohamed Elhadidi-MD A l e x a n d r i a F a c u l t y o f

More information

The role of esophageal brachytherapy

The role of esophageal brachytherapy Esophageal cancer is combination with surgery (stents) or EBRT a better solution? Razvan Galalae, MD, PhD Associate Professor, Medical Faculty, Christian Albrecht University Kiel, Germany, and Head of

More information

T of radiation treatment and surgical resection

T of radiation treatment and surgical resection BREAST CANCER-PREOPERATIVE AND POSTOPERATIVE RADIATION THERAPY WILLIAM E. POWERS, MD Our goal is to develop new methods of breast cancer treatment that produce results better than those usually obtained

More information

Carcinoma of the Esophagus and Achalasia

Carcinoma of the Esophagus and Achalasia Carcinoma of the Esophagus and Achalasia Juan C. Bolivar, M.D., and Thomas L. Herendeen, M.D. A lmost a century has elapsed since Fagge [5] originally reported in 1872 the association of carcinoma of the

More information

Interstitial Irradiation for Unresectable Carcinoma of the Lung

Interstitial Irradiation for Unresectable Carcinoma of the Lung THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 20 NUMBER 5 NOVEMBER 1975 Interstitial Irradiation for Unresectable Carcinoma

More information

Carcinoma of the Lung

Carcinoma of the Lung THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and

More information

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,

More information

Stenting for Esophageal Cancer Technical Issues and Outcomes

Stenting for Esophageal Cancer Technical Issues and Outcomes Stenting for Esophageal Cancer Technical Issues and Outcomes Moishe Liberman Director C.E.T.O.C. Division of Thoracic Surgery Centre Hospitalier de l Université de Montréal Disclosures Research and Educational

More information

A video demonstration of the Li s anastomosis the key part of the non-tube no fasting fast track program for resectable esophageal carcinoma

A video demonstration of the Li s anastomosis the key part of the non-tube no fasting fast track program for resectable esophageal carcinoma Surgical Technique A video demonstration of the the key part of the non-tube no fasting fast track program for resectable esophageal carcinoma Yan Zheng*, Yin Li*, Zongfei Wang, Haibo Sun, Ruixiang Zhang

More information

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives UPDATED: July 2009 ROTATION: THORACIC SURGERY UCLA General Surgery Residency Program ROTATION DIRECTOR: Mary Maish, M.D. CHIEF OF CARDIAC SURGERY: Robert Cameron, M.D. SITES: UCLA Medical Center - Westwood

More information

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,

More information

Chemotherapy for Adenocarcinoma and Alveolar Cell Carcinoma

Chemotherapy for Adenocarcinoma and Alveolar Cell Carcinoma Chemotherapy for Adenocarcinoma and Alveolar Cell Carcinoma of the Lung Scott L. Faulkner, M.D., R. Benton Adkins, Jr., M.D., and Vernon H. Reynolds, M.D. ABSTRACT Ten patients with inoperable or recurrent

More information

Lung Cancer in Women: A Different Disease? James J. Stark, MD, FACP

Lung Cancer in Women: A Different Disease? James J. Stark, MD, FACP Lung Cancer in Women: A Different Disease? James J. Stark, MD, FACP Medical Director, Cancer Program and Director of Palliative Care Maryview Medical Center Professor of Medicine Eastern Virginia Medical

More information

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis

A Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis Kitakanto Med J 2002 ; 52 : 189-193 189 A Proposed Strategy for Treatment of Superficial Carcinoma in the Thoracic Esophagus Based on an Analysis of Lymph Node Metastasis Susumu Kawate,' Susumu Ohwada,'

More information

PRINCIPLES OF RADIATION ONCOLOGY

PRINCIPLES OF RADIATION ONCOLOGY PRINCIPLES OF RADIATION ONCOLOGY Ravi Pachigolla, MD Faculty Advisor: Anna Pou, MD The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation January 5, 2000 HISTORY

More information

Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased

Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased analysis Roel Schlijper Fellow Radiation Oncology BC Cancer, Prince George Disclosures No conflicts

More information

Spinal Cord Doses in Palliative Lung Radiotherapy Schedules

Spinal Cord Doses in Palliative Lung Radiotherapy Schedules Journal of the Egyptian Nat. Cancer Inst., Vol. 8, No., June: -, 00 Spinal Cord Doses in Palliative Lung Radiotherapy Schedules HODA AL-BOOZ, FRCR FFRRCSI M.D.* and CAROL PARTON, Ph.D.** The Departments

More information

Laryngeal Conservation

Laryngeal Conservation Laryngeal Conservation Sarah Rodriguez, MD Faculty Advisor: Shawn Newlands, MD, PhD The University of Texas Medical Branch Department of Otolaryngolgy Grand Rounds Presentation February 2005 Introduction

More information

Is a Metallic Stent Useful for Non Resectable Esophageal Cancer?

Is a Metallic Stent Useful for Non Resectable Esophageal Cancer? Original Article Is a Metallic Stent Useful for Non Resectable Esophageal Cancer? Shinsuke Wada, MD, 1 Tsuyoshi Noguchi, MD, 1 Shinsuke Takeno, MD, 1 Hatsuo Moriyama, MD, 1 Tsuyoshi Hashimoto, MD, 1 Yuzo

More information

Clinical Evaluation of Computed Tomography in Esophageal Cancer

Clinical Evaluation of Computed Tomography in Esophageal Cancer THE KURUME MEDICAL JOURNAL Vol.28, p.53-61, 1981 Clinical Evaluation of Computed Tomography in Esophageal Cancer MASAYUKI HAMADA, YUKIHIKO YASUDA, SHINICHI NAKAYAMA, SHIGERU KIKUCHI, HARUMI AKAGAWA, KIYOSHI

More information

Stage 1 esophageal cancer survival rate

Stage 1 esophageal cancer survival rate Stage 1 esophageal cancer survival rate Search Below are the five-year survival rates for esophageal cancer patients treated by SCCA compared to patients who were treated for esophageal. Stage I Esophageal

More information

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment

More information

Стенты «Ella-cs» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts»

Стенты «Ella-cs» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts» Уважаемые коллеги! Высылаем очередной выпуск «Issue of ELLA Abstracts» A. Esophageal Stenting and related topics 1 AMJG 2009; 104:1329 1330 Letters to Editor Early Tracheal Stenosis Post Esophageal Stent

More information

Tumour size as a prognostic factor after resection of lung carcinoma

Tumour size as a prognostic factor after resection of lung carcinoma Tumour size as a prognostic factor after resection of lung carcinoma A. S. SOORAE AND R. ABBEY SMITH Thorax, 1977, 32, 19-25 From the Cardio-Thoracic Unit, Walsgrave Hospital, Clifford Bridge Road, Coventry

More information

Relevance of an Intensive Postoperative Follow-up After Surgery for Non Small Cell Lung Cancer

Relevance of an Intensive Postoperative Follow-up After Surgery for Non Small Cell Lung Cancer Relevance of an Intensive Postoperative Follow-up After Surgery for Non Small Cell Lung Cancer Virginie Westeel, MD, Didier Choma, MD, François Clément, MD, Marie-Christine Woronoff-Lemsi, PhD, Jean-François

More information

The Role of Radiotherapy in Metastatic Breast Cancer. Shilpen Patel MD, FACRO Associate Professor Departments of Radiation Oncology and Global Health

The Role of Radiotherapy in Metastatic Breast Cancer. Shilpen Patel MD, FACRO Associate Professor Departments of Radiation Oncology and Global Health The Role of Radiotherapy in Metastatic Breast Cancer Shilpen Patel MD, FACRO Associate Professor Departments of Radiation Oncology and Global Health Indications for Palliative Pain Control Radiation Bone

More information

Intra-arterial chemotherapy for patients with

Intra-arterial chemotherapy for patients with Annals of the Royal College of Surgeons of England (980) vol 62 ASPECTS OF TREATMENT* ntra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas Lord Smith of Marlow KBE MS PPRCS

More information

Radiation Therapy for Recurrent Esophageal Cancer after Surgery: Clinical Results and Prognostic Factors

Radiation Therapy for Recurrent Esophageal Cancer after Surgery: Clinical Results and Prognostic Factors Radiation Therapy for Recurrent Esophageal Cancer after Surgery: Clinical Results and Prognostic Factors Yoshiyuki Shioyama 1, Katsumasa Nakamura 1, Saiji Ohga 1, Satoshi Nomoto 1, Tomonari Sasaki 1, Toshihiro

More information

I ing therapy, the most commonly used index

I ing therapy, the most commonly used index WHEN MAY ENDOMETRIAL CANCER BE CONSIDERED CURED? RICHARD R. MONSON, MD,* BRIAN MACMAHON, &ID,* AND JAMES H. AUSTIN, MD+ To assess when a woman may be considered cured following treatment for endometrial

More information

17. Oesophagus. Upper gastrointestinal cancer

17. Oesophagus. Upper gastrointestinal cancer 110 17. Upper gastrointestinal cancer Oesophagus Radical treatment For patients with localised disease, the standard curative approach to treatment is either surgery + perioperative chemotherapy, surgery

More information

The effects of fast neutrons on inoperable carcinoma of the stomach

The effects of fast neutrons on inoperable carcinoma of the stomach Gut, 1975, 16, 150-156 The effects of fast neutrons on inoperable carcinoma of the stomach MARY CATTERALL, DEREK KINGSLEY, GILBERT LAWRENCE, JOHN GRAINGER, AND JOHN SPENCER From the Medical Research Council's

More information

Hodgkin s Disease of the Mediastinum

Hodgkin s Disease of the Mediastinum THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 3 NUMBER 4 APRIL 1967 Hodgkin s Disease of the Mediastinum William A. Burke,

More information

Palliative RT in Ovarian cancer

Palliative RT in Ovarian cancer Outline Palliative RT in Ovarian cancer Case discussion Palliative treatment Radiation Techniques Asst Prof Pittaya Dankulchai, MD. Division of Radiation Oncology, Department of Radiology, Faculty of Medicine

More information

MANAGEMENT OF CA HYPOPHARYNX

MANAGEMENT OF CA HYPOPHARYNX MANAGEMENT OF CA HYPOPHARYNX GENERAL TREATMENT RECOMMENDATIONS BASED ON HYPOPHARYNX TUMOR STAGE For patients presenting with early-stage definitive radiotherapy alone or voice-preserving surgery are viable

More information

THE MANAGEMENT OF THE SWOLLEN ARM IN CARCINOMA OF THE BREAST

THE MANAGEMENT OF THE SWOLLEN ARM IN CARCINOMA OF THE BREAST THE MANAGEMENT OF THE SWOLLEN ARM IN CARCINOMA OF THE BREAST NORMAN TREVES, M.D. The terms "brawny arm" and "lymphedema" have been given to the swollen arm which may complicate the inoperable, recurrent,

More information

The Effects of Preoperative Irradiation

The Effects of Preoperative Irradiation The Effects of Preoperative Irradiation on Primary Tracheal Anastomosis N. Tsubota, M.D., W. J. Simpson, M.D., A. W. P. Van Nostrand, M.D., and F. G. Pearson, M.D. ABSTRACT Preoperative radiotherapy was

More information

Medicinae Doctoris. One university. Many futures.

Medicinae Doctoris. One university. Many futures. Medicinae Doctoris The Before and The After: Can chemotherapy revise the trajectory of gastric and esophageal cancers? Dr. David Dawe MD, FRCPC Medical Oncologist Assistant Professor Disclosures None All

More information

Hong-Gyun Wu, M.D., Charn Il Park, M.D., S ung Whan Ha, M.D., and Il Han Kim, M.D.

Hong-Gyun Wu, M.D., Charn Il Park, M.D., S ung Whan Ha, M.D., and Il Han Kim, M.D. J. Korean Soc Ther Radiol Oncol 1999;17(1):108 112 1) S ign ifica nce of S uprac lav ic ula r Lymph Node Invo lve me nt o n Dete rm inat io n of Clin ica l Stag ing fo r Tho rac ic Es o phagea l Ca rc

More information

Clinical patterns and treatment complications of 1000 cases of carcinoma of the uterine cervix

Clinical patterns and treatment complications of 1000 cases of carcinoma of the uterine cervix Med. J. Malaysia Vol. 44 No. 2 June 1989 Clinical patterns and treatment complications of 1000 cases of carcinoma of the uterine cervix Tahir Azhar, MBBS, MRCP, DMRT, FFR Lecturer and Consultant Oncologist-Radiotherapist

More information

Early View Article: Online published version of an accepted article before publication in the final form.

Early View Article: Online published version of an accepted article before publication in the final form. : Online published version of an accepted article before publication in the final form. Journal Name: Journal of Case Reports and Images in Surgery Type of Article: Case Report Title: What is the treatment

More information

肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部

肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation

More information

Radiation Schedules for Palliation in Carcinoma Esophagus

Radiation Schedules for Palliation in Carcinoma Esophagus ORIGINAL ARTICLE Radiation Schedules for Palliation in Carcinoma Esophagus B S Yadav, R Kapoor, S C Sharma, R Kochhar*, F D Patel This study was undertaken to compare the three different radiation schedules

More information

Esophageal cancer is a significant health hazard for

Esophageal cancer is a significant health hazard for Postoperative Radiotherapy Improved Survival of Poor Prognostic Squamous Cell Carcinoma Esophagus GENERAL THORACIC Junqiang Chen, MD, Ji Zhu, MD, Jianji Pan, MD, Kunshou Zhu, MD, Xiongwei Zheng, MD, Mingqiang

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.

More information

Parameters Linked to Ten-Year Survival in Japan of Resected Esophageal Carcinoma

Parameters Linked to Ten-Year Survival in Japan of Resected Esophageal Carcinoma Parameters Linked to Ten-Year Survival in Japan of Resected Esophageal Carcinoma Japanese Committee for Registration ofesophageal Carcinoma Cases Chairman: Toshifumi lizuka, M.D.* Members: Kaichi lsono,

More information

Causes of Treatment Failure and Death in Carcinoma of the Lung

Causes of Treatment Failure and Death in Carcinoma of the Lung THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 201-207 Causes of Treatment Failure and Death in Carcinoma of the Lung JAMES D. COX, M.D.,a AND RAYMOND A. YESNER, M.D.b The Medical College of Wisconsin,

More information

Primary Tumors of Ribs

Primary Tumors of Ribs Primary Tumors of Ribs Frank E. Schmidt, M.D., and Max J. Trummer, Capt, MC, USN ABSTRACT An analysis of 50 consecutive patients with primary rib tumors operated on at the U.S. Naval Hospital, San Diego,

More information

Department of Otolaryngology, Kurume University School of Medicine, Kurume, Japan

Department of Otolaryngology, Kurume University School of Medicine, Kurume, Japan THE KURUME MEDICAL JOURNAL Vol. 16, No. 3, 1969 PATHOLOGICAL STUDIES RELATING TO NEOPLASMS OF THE HYPOPHARYNX AND THE CERVICAL ESOPHAGUS IKUICHIRO HIROTO, YASUSHI NOMURA, KUSUO SUEYOSHI, SHIGENOBU MITSUHASHI,

More information

Treatment for Supraglottic Ca History: : Total Laryngectomy y was routine until early 50 s, when XRT was developed Ogura and Som developed the one-sta

Treatment for Supraglottic Ca History: : Total Laryngectomy y was routine until early 50 s, when XRT was developed Ogura and Som developed the one-sta Role of Laser Therapy in Laryngeal Cancer Khalid Hussain AL-Qahtani MD,MSc,FRCS(c) MSc Assistant Professor Consultant of Otolaryngology Advance Head & Neck Oncology, Thyroid & Parathyroid,Microvascular

More information

Lymph node metastasis is one of the most important prognostic

Lymph node metastasis is one of the most important prognostic ORIGINAL ARTICLE Comparison of Survival and Recurrence Pattern Between Two-Field and Three-Field Lymph Node Dissections for Upper Thoracic Esophageal Squamous Cell Carcinoma Young Mog Shim, MD, Hong Kwan

More information

Case presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium

Case presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Case presentation Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Perspectives in Lung Cancer Brussels 6-7 march 2009 LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery

More information

THORACIC MALIGNANCIES

THORACIC MALIGNANCIES THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,

More information

Radiotherapy in feline and canine head and neck cancer

Radiotherapy in feline and canine head and neck cancer Bettina Kandel Like surgery radiotherapy is usually a localized type of treatment. Today it is more readily available for the treatment of cancer in companion animals and many clients are well informed

More information

Adjuvant therapy for thyroid cancer

Adjuvant therapy for thyroid cancer Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women

More information

The Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma

The Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma The Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma G. A. Patterson, M.D., R. Ilves, M.D., R. J. Ginsberg, M.D., J. D. Cooper, M.D., T. R. J. Todd, M.D.,

More information

Dr. Noelle O Rourke Beatson Oncology Centre, Glasgow RADIOTHERAPY FOR LYMPHOMA???

Dr. Noelle O Rourke Beatson Oncology Centre, Glasgow RADIOTHERAPY FOR LYMPHOMA??? Dr. Noelle O Rourke Beatson Oncology Centre, Glasgow RADIOTHERAPY FOR LYMPHOMA??? History of Radiotherapy 1895 Rontgen describes X-rays 1896 Becquerel radioactivity 1905 Radiation is used to treat tumours

More information

Although esophagectomy remains the standard of care for esophageal

Although esophagectomy remains the standard of care for esophageal Keresztes et al General Thoracic Surgery Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: Results of a phase II trial R. S. Keresztes, MD J. L. Port, MD M. W. Pasmantier,

More information

Refresher Course EAR TUMOR. Sasikarn Chamchod, MD Chulabhorn Hospital

Refresher Course EAR TUMOR. Sasikarn Chamchod, MD Chulabhorn Hospital Refresher Course EAR TUMOR Sasikarn Chamchod, MD Chulabhorn Hospital Reference: Perez and Brady s Principles and Practice of radiation oncology sixth edition Outlines Anatomy Epidemiology Clinical presentations

More information

CURRENT PRACTICE OF FOLLOW-UP MANAGEMENT AFTER POTENTIALLY CURATIVE RESECTION OF RECTAL CANCER

CURRENT PRACTICE OF FOLLOW-UP MANAGEMENT AFTER POTENTIALLY CURATIVE RESECTION OF RECTAL CANCER CURRENT PRACTICE OF FOLLOW-UP MANAGEMENT AFTER POTENTIALLY CURATIVE RESECTION OF RECTAL CANCER 1. a. If you are retired, or do not perform such surgery, please check the box at the right, answer questions

More information

Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria Hospital MONTREAL

Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria Hospital MONTREAL Eating Drinking, Living after Curative Therapy for Esophageal cancer Dr. Martin Chasen Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria

More information

Esophageal Cancer. What is esophageal cancer?

Esophageal Cancer. What is esophageal cancer? Scan for mobile link. Esophageal Cancer Esophageal cancer occurs when cancer cells develop in the esophagus. The two main types are squamous cell carcinoma and adenocarcinoma. Esophageal cancer may not

More information

Lung Cancer Update. HARMESH R NAIK, MD. February 28, 2001

Lung Cancer Update. HARMESH R NAIK, MD. February 28, 2001 Lung Cancer Update HARMESH R NAIK, MD. February 28, 2001 Progress update Prevention Screening Staging Treatment Epidemiology Estimated 169,500 new cases Estimated 157,400 deaths Second commonest cancer

More information

Although the international TNM classification system

Although the international TNM classification system Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru

More information

Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases

Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation

More information

The Learning Curve for Minimally Invasive Esophagectomy

The Learning Curve for Minimally Invasive Esophagectomy The Learning Curve for Minimally Invasive Esophagectomy AATS Focus on Thoracic Surgery Mastering Surgical Innovation Las Vegas Nevada Oct. 27-28 2017 Scott J Swanson, M.D. Professor of Surgery Harvard

More information

Postoperative Radiotherapy for Completely Resected Stage II or III Thymoma

Postoperative Radiotherapy for Completely Resected Stage II or III Thymoma ORIGINAL ARTICLE Postoperative Radiotherapy for Completely Resected Stage II or III Thymoma Ji Hyun Chang, MD,* Hak Jae Kim, MD, PhD,* Hong-Gyun Wu, MD, PhD,* Joo Hyun Kim, MD, PhD, and Young Tae Kim,

More information

THE TREATMENT OF ADVANCED MALIGNANT DISEASE BY RADIOTHERAPY AND SURGERY

THE TREATMENT OF ADVANCED MALIGNANT DISEASE BY RADIOTHERAPY AND SURGERY THE TREATMENT OF ADVANCED MALIGNANT DISEASE BY RADIOTHERAPY AND SURGERY By F. ELLIS, M.D., M.Sc., F.R.C.P., F.F.R., and T. J. S. PATTERSON, M.D., M.Chir., F.R.C.S. From the Departments of Radiotherapy

More information

Chapter 8 Adenocarcinoma

Chapter 8 Adenocarcinoma Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

More information

Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes

Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes Journal of Radiation Research, 2013, 54, 307 314 doi: 10.1093/jrr/rrs096 Advance Access Publication 2 November 2012 Impact of esophageal cancer staging on overall survival and disease-free survival based

More information

The Itracacies of Staging Patients with Suspected Lung Cancer

The Itracacies of Staging Patients with Suspected Lung Cancer The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung

More information

Determining the Optimal Surgical Approach to Esophageal Cancer

Determining the Optimal Surgical Approach to Esophageal Cancer Determining the Optimal Surgical Approach to Esophageal Cancer Amit Bhargava, MD Attending Thoracic Surgeon Department of Cardiovascular and Thoracic Surgery Open Esophagectomy versus Minimally Invasive

More information

Outcomes Following Negative Prostate Biopsy for Patients with Persistent Disease after Radiotherapy for Prostate Cancer

Outcomes Following Negative Prostate Biopsy for Patients with Persistent Disease after Radiotherapy for Prostate Cancer Clinical Urology Post-radiotherapy Prostate Biopsy for Recurrent Disease International Braz J Urol Vol. 36 (1): 44-48, January - February, 2010 doi: 10.1590/S1677-55382010000100007 Outcomes Following Negative

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Head and Neck Service

Head and Neck Service Head and Neck Service University of California, San Francisco, Department of Radiation Oncology Residency Training Program Head and Neck and Thoracic Service Educational Objectives for PGY-5 Residents

More information

The role of chemoradiotherapy in GE junction and gastric cancer. Karin Haustermans

The role of chemoradiotherapy in GE junction and gastric cancer. Karin Haustermans The role of chemoradiotherapy in GE junction and gastric cancer Karin Haustermans Overview Postoperative chemoradiotherapy Preoperative chemoradiotherapy Palliative radiation Technical aspects Overview

More information

General introduction and outline of thesis

General introduction and outline of thesis General introduction and outline of thesis General introduction and outline of thesis 11 GENERAL INTRODUCTION AND OUTLINE OF THESIS The incidence of esophageal cancer is increasing in the western world.

More information

The effect of early versus delayed radiation therapy on length of hospital stay in the palliative setting

The effect of early versus delayed radiation therapy on length of hospital stay in the palliative setting Original Article on Palliative Radiotherapy The effect of early versus delayed radiation therapy on length of hospital stay in the palliative setting Taylor R. Cushman 1, Shervin Shirvani 2, Mohamed Khan

More information

Surgical treatment of post-cricoid carcinoma

Surgical treatment of post-cricoid carcinoma Thorax (1968), 23, 550. Surgical treatment of post-cricoid carcinoma KENNETH MULLARD From the Wessex Cardiac and Thoracic Unit, Chest Hospital, Southampton Experience of the treatment of 20 patients with

More information

Treatment strategy of metastatic rectal cancer

Treatment strategy of metastatic rectal cancer 35.Schweizerische Koloproktologie-Tagung Treatment strategy of metastatic rectal cancer Gilles Mentha University hospital of Geneva Bern, January 18th, 2014 Colorectal cancer is the third most frequent

More information

Traditional Approaches to Treating NSCLC, Part 2: Neoadjuvant Combined Modality, Locally Advanced, and Metastatic NSCLC

Traditional Approaches to Treating NSCLC, Part 2: Neoadjuvant Combined Modality, Locally Advanced, and Metastatic NSCLC Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Head and Neck Cancer Treatment

Head and Neck Cancer Treatment Scan for mobile link. Head and Neck Cancer Treatment Head and neck cancer overview The way a particular head and neck cancer behaves depends on the site in which it arises (the primary site). For example,

More information

I cancer of the breast offers significant benefit

I cancer of the breast offers significant benefit DYSPHAGIA AND ESOPHAGEAL STENOSIS Manifestation of Metastatic Mammary Cancer HIRAM C. POLK, JR., MD,* MAJ. FRANK A. CAMP, MC, USAF, AND ANDREW W. WALKER, MD A remarkably uniform syndrome of dysphagia due

More information

Significance of Metastatic Disease

Significance of Metastatic Disease Significance of Metastatic Disease in Subaortic Lymph Nodes G. A. Patterson, M.D., D. Piazza, M.D., F. G. Pearson, M.D., T. R. J. Todd, M.D., R. J. Ginsberg, M.D., M. Goldberg, M.D., P. Waters, M.D., D.

More information

Effective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,

Effective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide, Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the

More information

HYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee

HYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee HYPERTHERMIA in CERVIX and VAGINA CANCER J. van der Zee ESTRO 2006 Deep hyperthermia in Rotterdam HYPERTHERMIA in CERVIX and VAGINA CANCER ESTRO 2006 Hyperthermia and radiotherapy in primary advanced cervix

More information

I to speak to you on the subject of radiotherapy

I to speak to you on the subject of radiotherapy A SURGEON LOOKS AT RADIOTHERAPY IN CANCER OF THE COLON AND RECTUM STUART H. Q. QUAN, MD* T MAY SEEM ODD THAT A SURGEON HAS CHOSEN I to speak to you on the subject of radiotherapy in the management of cancer

More information

Painful vertebral metastases are a frequent manifestation of malignancies

Painful vertebral metastases are a frequent manifestation of malignancies 2892 COMMUNICATION Palliative Radiation Therapy for Painful Vertebral Metastases A Practice Survey Tejpal Gupta, M.D., D.N.B. Rajiv Sarin, M.D. Department of Radiation Oncology, Tata Memorial Hospital,

More information

ORIGINAL ARTICLE. The Kirschner Operation in Unresectable Esophageal Cancer

ORIGINAL ARTICLE. The Kirschner Operation in Unresectable Esophageal Cancer The Kirschner Operation in Unresectable Esophageal Cancer Current Application ORIGINAL ARTICLE Brian P. Whooley, MD; Simon Law, MBBChir, FRCS(Edin); Sudish C. Murthy, MD, PhD; Andreas Alexandrou, MD; Kent-Man

More information

Pulmonary Resection for Metastases from Colorectal Cancer

Pulmonary Resection for Metastases from Colorectal Cancer ORIGINAL ARTICLE Pulmonary Resection for Metastases from Colorectal Cancer Paul M. van Schaik, MD,* Ewout A. Kouwenhoven, MD, PhD,* Robert J. Bolhuis, MD,* Bonne Biesma, MD, PhD, and Koop Bosscha, MD,

More information

Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference?

Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference? Diseases of the Esophagus (2008) 21, 596 600 DOI: 10.1111/j.1442-2050.2008.00817.x Original article Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma:

More information